Impact of Electrical Cardioversion on Quality of Life for the Treatment of Atrial Fibrillation

Perceptions and experiences of MediYoga among patients with paroxysmal atrial fibrillation—An interview study

“…In SF-36 is a well-known assessment instrument, takes 10-15 minutes to answer and has been used worldwide in various AF contexts (35,(138)(139)(140)(141).…”

Assessment of the association between quality of life in patients with atrial fibrillation and cardiovascular outcomes during the one-year follow-up

“…Analiza komponenata AFEQT skora je pokazala da su ispitanici najveći značaj za sniženje QoL pridali tegobama i ograničenju aktivnosti, što ukazuje na važnost terapijskih mera koje imaju za cilj da se regulacijom srčane frekvencije za vreme AF, kardioverzijom u sinusni ritam ili ablacijom AF koriguju tegobe i poveća tolerancija fizič-kog napora (22)(23)(24). Sa druge strane, pacijenti nisu izrazili veću zabrinutosti zbog mogućih posledica AF i primenjene terapije i visoko su ocenili zadovoljstvo sprovedenim lečenjem.…”

Cardioversion for Atrial Fibrillation Improves Quality of Life: It's Obvious (or Isn't It?)

“…Sandhu and colleagues, in their prospective study of the effect of electrical cardioversion on quality of life in this issue of the Canadian Journal of Cardiology provide some useful information to help clinicians navigate these decisions. 6 This study helps us understand the magnitude of quality of life change after cardioversion in patients with persistent AF. 6 They studied a population of patients that was younger, and had less comorbidity, than the "average" patient seen with AF in community practice, and who were less often treated with antiarrhythmic drugs after electrical cardioversion than might have been expected among patients who had been in AF for at least a month, and many more than 6 months.…”

“…6 This study helps us understand the magnitude of quality of life change after cardioversion in patients with persistent AF. 6 They studied a population of patients that was younger, and had less comorbidity, than the "average" patient seen with AF in community practice, and who were less often treated with antiarrhythmic drugs after electrical cardioversion than might have been expected among patients who had been in AF for at least a month, and many more than 6 months. It might thus be surmised that many patients in this study were likely to have AF as a "primary clinical problem," rather than accompanying common comorbidities such as heart failure, coronary disease, and hypertension, which are often found in patients with AF.…”

“…Second, there is a wide variation of quality of life among the patients in this study, in those remaining in sinus rhythm as well as in those in whom AF recurred. Unfortunately, in their article, Sandhu et al 6 do not describe the distribution of changes in quality of life from baseline to 3 months across all the patients, and in the groups destined to maintain sinus rhythm or have AF recurrence. Previous studies 7,8 have shown that there is a very wide variation of change in quality of life with treatment, including after restoration of sinus rhythm.…”